Company Filing History:
Years Active: 2013
Title: Innovations by Kara Joyce Sedoris in Cancer Treatment
Introduction
Kara Joyce Sedoris is an accomplished inventor based in Louisville, KY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. Her work focuses on developing compositions and methods that inhibit cellular growth and induce cell death, providing new avenues for cancer therapy.
Latest Patents
Kara Joyce Sedoris holds a patent for "Compositions and methods for treating cancer, inhibiting proliferation, and inducing cell death." This patent describes the use of quadruplex-forming guanine-rich nucleic acid sequences that are effective in inhibiting cellular growth and promoting cell death. The compositions include a safe and effective amount of a sequence with at least 80% nucleic acid identity with a guanine-rich promoter gene oligonucleotide (GPGO), along with a carrier that allows the oligonucleotide to form at least one quadruplex. This innovative approach has the potential to significantly impact cancer treatment strategies.
Career Highlights
Kara Joyce Sedoris is affiliated with the University of Louisville Research Foundation, Inc., where she continues her research and development efforts. Her work has garnered attention for its potential applications in medical science, particularly in oncology. With her dedication to advancing cancer treatment, she has established herself as a key figure in her field.
Collaborations
Kara has collaborated with notable colleagues, including Donald Miller and Shelia Diann Thomas. These partnerships have enhanced her research efforts and contributed to the development of her innovative cancer treatment methods.
Conclusion
Kara Joyce Sedoris is a pioneering inventor whose work in cancer treatment exemplifies the intersection of innovation and medical research. Her patented methods and compositions hold promise for improving patient outcomes in the fight against cancer.